Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "CKLF-like MARVEL transmembrane domain containing 6 pseudogene" (ENSG00000271546) is a noncoding, nonfunctional genetic element arising from the duplication or retrotransposition of a related functional gene, likely CMTM6. Pseudogenes like this are characterized by high sequence similarity to protein-coding genes but contain disabling mutations (such as frameshifts or premature stop codons) that prevent them from producing a functional protein. This specific pseudogene is not expected to have a biological role and is not considered a therapeutic target, enzyme, receptor, or biomarker. Pseudogenes complicate genome annotation and may occasionally impact gene regulation as noncoding RNAs, but no such function is known for this entry[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CKLF-like MARVEL transmembrane domain containing 6 pseudogene.